| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JXHL1900033 | Padsevonil片 | padsevonil | Tablet | Chemical Drugs(1) | Import Drug Application | 2019-02-27 | UCB Pharma SA | UCB Pharma SA | In Review | 2019-02-26 | view |
| JXHL1900032 | Padsevonil片 | padsevonil | Tablet | Chemical Drugs(1) | Import Drug Application | 2019-02-22 | UCB Pharma SA | UCB Pharma SA | In Review | 2019-02-21 | view |
| JXHL1900031 | Padsevonil片 | padsevonil | Tablet | Chemical Drugs(1) | Import Drug Application | 2019-02-22 | UCB Pharma SA | UCB Pharma SA | In Review | 2019-02-21 | view |
| JXSL1600073 | 培化舍组单抗注射液 | Injection | Biological Products | Import Drug Application | 2017-01-19 | UCB Pharma SA | UCB Pharma SA | Certificate Issued | 2018-06-04 | view | |
| JXSS1800003 | 培塞利珠单抗注射液 | certolizumab pegol | Injection | Biological Products | Import Drug Application | 2018-03-30 | UCB Pharma SA | UCB Pharma SA | Certificate Issued | 2019-07-16 | view |
| JXHL1200017 | 布瓦西坦片 | brivaracetam | Tablet | Chemical Drugs | Import Drug Application | 2012-01-29 | UCB Pharma SA | UCB Pharma SA | Certificate Issued | 2013-10-21 | view |
| JXHL1200016 | 布瓦西坦片 | brivaracetam | Tablet | Chemical Drugs | Import Drug Application | 2012-02-09 | UCB Pharma SA | UCB Pharma SA | Certificate Issued | 2013-10-21 | view |
| JXHL1200018 | 布瓦西坦片 | brivaracetam | Tablet | Chemical Drugs | Import Drug Application | 2012-01-29 | UCB Pharma SA | UCB Pharma SA | Certificate Issued | 2013-10-21 | view |
| JXHL2000052 | 布立西坦片 | brivaracetam | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2020-03-19 | UCB Pharma SA | UCB Pharma SA | In Review | 2020-03-18 | view |
| JXHL1700034 | 布立西坦片 | brivaracetam | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2017-03-06 | UCB Pharma SA | UCB Pharma SA | Certificate Issued | 2018-07-09 | view |
| JXHL1700032 | 布立西坦片 | brivaracetam | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2017-03-06 | UCB Pharma SA | UCB Pharma SA | Certificate Issued | 2018-07-09 | view |
| JXHL2000051 | 布立西坦片 | brivaracetam | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2020-03-19 | UCB Pharma SA | UCB Pharma SA | In Review | 2020-03-18 | view |
| JXHL1700033 | 布立西坦片 | brivaracetam | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2017-03-06 | UCB Pharma SA | UCB Pharma SA | Certificate Issued | 2018-07-09 | view |
| JXHL1700036 | 布立西坦片 | brivaracetam | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2017-03-06 | UCB Pharma SA | UCB Pharma SA | Certificate Issued | 2018-07-09 | view |
| JXHL2000050 | 布立西坦片 | brivaracetam | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2020-03-19 | UCB Pharma SA | UCB Pharma SA | In Review | 2020-03-18 | view |
| JXHL1700035 | 布立西坦片 | brivaracetam | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2017-03-06 | UCB Pharma SA | UCB Pharma SA | Certificate Issued | 2018-07-09 | view |
| JXHL2000049 | 布立西坦片 | brivaracetam | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2020-03-19 | UCB Pharma SA | UCB Pharma SA | In Review | 2020-03-18 | view |
| JXHL2000048 | 布立西坦片 | brivaracetam | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2020-03-19 | UCB Pharma SA | UCB Pharma SA | In Review | 2020-03-18 | view |
| JXHS1800071 | 拉考沙胺注射液 | lacosamide | Injection | Chemical Drugs(5.1) | Import Drug Application | 2018-12-07 | UCB Pharma SA | UCB Pharma SA | Certificate Issued | 2019-12-23 | view |
| JXHL1500321 | 拉考沙胺片 | lacosamide | Tablet | Chemical Drugs | Import Drug Application | 2016-01-05 | UCB Pharma SA | UCB Pharma SA | Certificate Issued | 2016-09-05 | view |